The actress, who died from complications of breast cancer at 76, pioneered the role of celebrity wellness guru, but drew criticism when it was revealed she had skipped chemotherapy against the advice of her doctor.
The nation had made progress in closing the gap between white and Black mortality rates – fueled by heart disease, cancer and infant mortality – but then COVID hit, according to a new JAMA study.
An exclusive analysis for Kaiser Health News found that only 48 percent of eligible breast cancer patients today get a recommended shorter radiation regimen, in spite of the additional costs and inconvenience of the longer type.
Costs for CAR T-cell therapies will be far higher than many have imagined, reaching $1 million or more per patient, according to leading cancer experts. The next CAR T-cell drug could be approved as soon as November.
DebugScreen: mobile
{
"author": {
"name": "Liz Szabo",
"webUrl": "/author/profile/liz-szabo/",
"description": "",
"imageLarge": "https://secure.gravatar.com/avatar/f16d6fc2845f417ea0e93a3f2b6cd37d?s=136&d=mm&r=g",
"estimate": 8,
"social": [],
"articles": [
{
"uri": "/2023/10/23/suzanne-somers-legacy-tainted-by-celebrity-medical-misinformation/",
"title": "Is Suzanne Somers' legacy tainted by celebrity medical misinformation?",
"byline": "Liz Szabo",
"kicker": "Commentary",
"prettyDate": "October 23, 2023",
"timeToRead": "5 minute",
"image": {
"uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2023/10/Suzanne-Somers-Article-202310191516.jpg",
"width": "621",
"height": "372"
},
"authors": [
{
"webUrl": "/author/profile/liz-szabo/",
"name": "Liz Szabo"
}
],
"kickerNode": [
{
"uri": "/commentary/",
"sectionName": "Commentary"
}
],
"summary": "The actress, who died from complications of breast cancer at 76, pioneered the role of celebrity wellness guru, but drew criticism when it was revealed she had skipped chemotherapy against the advice of her doctor.",
"body": null
},
{
"uri": "/2023/05/19/study-reveals-staggering-toll-of-being-black-in-america-1-6m-excess-deaths-over-22-years/",
"title": "Alarming health disparities: Black Americans experienced 1.6M 'excess deaths' over 20 years",
"byline": "Liz Szabo",
"kicker": "Research",
"prettyDate": "May 19, 2023",
"timeToRead": "6 minute",
"image": {
"uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2020/09/Diversity-Article-202009111141.jpg",
"width": "620",
"height": "372"
},
"authors": [
{
"webUrl": "/author/profile/liz-szabo/",
"name": "Liz Szabo"
}
],
"kickerNode": [
{
"uri": "/research/",
"sectionName": "Research"
}
],
"summary": "The nation had made progress in closing the gap between white and Black mortality rates – fueled by heart disease, cancer and infant mortality – but then COVID hit, according to a new JAMA study.",
"body": null
},
{
"uri": "/2020/09/03/are-americans-ready-for-a-covid-19-vaccine/",
"title": "Is America ready for a COVID-19 vaccine?",
"byline": "Liz Szabo, Kaiser Health News",
"kicker": "News",
"prettyDate": "September 03, 2020",
"timeToRead": "11 minute",
"image": {
"uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2020/07/Injection-Article-202007222110.jpg",
"width": "0",
"height": "0"
},
"authors": [
{
"webUrl": "/author/profile/liz-szabo-kaiser-health-news/",
"name": "Liz Szabo, Kaiser Health News"
}
],
"kickerNode": [
{
"uri": "/news/",
"sectionName": "News"
}
],
"summary": "The CDC's has told governors to have vaccine distribution sites up and running by Nov. 1, but there's a lot more work to be done.",
"body": null
},
{
"uri": "/2019/12/31/artificial-intelligence-and-health-care-the-revolution-has-not-yet-come/",
"title": "Artificial intelligence and health care: The revolution has not yet come",
"byline": "Liz Szabo, Kaiser Health News",
"kicker": "Market Insights",
"prettyDate": "December 31, 2019",
"timeToRead": "13 minute",
"image": {
"uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2018/02/MedicalTech.jpg",
"width": "600",
"height": "400"
},
"authors": [
{
"webUrl": "/author/profile/liz-szabo-kaiser-health-news/",
"name": "Liz Szabo, Kaiser Health News"
}
],
"kickerNode": [
{
"uri": "/market-insights/",
"sectionName": "Market Insights"
}
],
"summary": "Many doctors and consumer advocates fear that the tech industry, which lives by the mantra \"fail fast and fix it later,\" is putting patients at risk.",
"body": null
},
{
"uri": "/2019/06/26/can-employers-save-money-with-stem-cell-therapy/",
"title": "Can employers save money with stem cell therapy?",
"byline": "Liz Szabo, Kaiser Health News",
"kicker": "Investigation",
"prettyDate": "June 26, 2019",
"timeToRead": "12 minute",
"image": {
"uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2018/04/DrugVials.jpg",
"width": "600",
"height": "400"
},
"authors": [
{
"webUrl": "/author/profile/liz-szabo-kaiser-health-news/",
"name": "Liz Szabo, Kaiser Health News"
}
],
"kickerNode": [
{
"uri": "/investigation/",
"sectionName": "Investigation"
}
],
"summary": "Hundreds of employers now include stem cell therapy in their insurance coverage, but is it worth the cost? ",
"body": null
},
{
"uri": "/2018/11/06/precision-medicine-worth-the-expense/",
"title": "Precision medicine: worth the expense?",
"byline": "Liz Szabo, Kaiser Health News",
"kicker": "Market Insights",
"prettyDate": "November 06, 2018",
"timeToRead": "7 minute",
"image": {
"uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2018/04/DrugVials.jpg",
"width": "600",
"height": "400"
},
"authors": [
{
"webUrl": "/author/profile/liz-szabo-kaiser-health-news/",
"name": "Liz Szabo, Kaiser Health News"
}
],
"kickerNode": [
{
"uri": "/market-insights/",
"sectionName": "Market Insights"
}
],
"summary": "The high cost of cutting-edge tests and treatments is threatening to keep precision medicine out of reach for many patients.",
"body": null
},
{
"uri": "/2017/10/23/unneeded-tests-outdated-treatments-adding-to-patie/",
"title": "Unneeded tests, outdated treatments adding to patients' woes",
"byline": " Liz Szabo, Kaiser Health News ",
"kicker": "",
"prettyDate": "October 23, 2017",
"timeToRead": "11 minute",
"image": {
"uri": "",
"width": "",
"height": ""
},
"authors": [
{
"webUrl": "/author/profile/liz-szabo-kaiser-health-news/",
"name": "Liz Szabo, Kaiser Health News"
}
],
"kickerNode": [],
"summary": "An exclusive analysis for Kaiser Health News found that only 48 percent of eligible breast cancer patients today get a recommended shorter radiation regimen, in spite of the additional costs and inconvenience of the longer type.",
"body": null
},
{
"uri": "/2017/10/18/1-million-per-person-cancer-treatments-coming/",
"title": "$1 million (per person) cancer treatments coming",
"byline": "Liz Szabo, Kaiser Health News",
"kicker": "",
"prettyDate": "October 18, 2017",
"timeToRead": "7 minute",
"image": {
"uri": "",
"width": "",
"height": ""
},
"authors": [
{
"webUrl": "/author/profile/liz-szabo-kaiser-health-news/",
"name": "Liz Szabo, Kaiser Health News"
}
],
"kickerNode": [],
"summary": "Costs for CAR T-cell therapies will be far higher than many have imagined, reaching $1 million or more per patient, according to leading cancer experts. The next CAR T-cell drug could be approved as soon as November.",
"body": null
}
]
}
}
